Documentos relacionados

1. Invited commentary.
2. Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease. Reply.
3. Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease.
4. Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease.
5. Selective referral or learning by doing? An analysis of hospital volume-outcome relationship of vascular procedures.
6. Tandem Occlusions: A Tale of Two Treatments.
7. Paclitaxel and Mortality: Where Are We now?
8. Should Multiple Vessels be Recanalised for Tissue Loss Irrespective of Pedal Anatomy and Angiosome?
9. Letter by Su et al Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)".
10. Response by Weinberg et al to Letter Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)".